Transient Ischemic Attack clinical trials at UC Irvine
1 in progress, 0 open to eligible people
Showing trials for
Milvexian in Participants After an Acute Ischemic Stroke or High-Risk Transient Ischemic Attack- LIBREXIA-STROKE
Sorry, in progress, not accepting new patients
The purpose of this study is to evaluate whether milvexian compared to placebo reduce the risk of recurrent ischemic stroke.
Irvine, California and other locations
Our lead scientists for Transient Ischemic Attack research studies include Jay Shah.
Last updated: